Research ExplorerScientific StaffCarsten Bokemeyer Publications

Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations
Affiliations
551 - 600 out of 794Page size: 50

Publications

  1. 2012

  2. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.

    Langer, F. & Bokemeyer, C., 2012, In: HAMOSTASEOLOGIE. 32, 2, p. 95-104 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. [EAU guidelines on testicular cancer: 2011 update].

    Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K., Horwich, A., Laguna, M. P. & Urology, E. A. O., 2012, In: ACTAS UROL ESP. 36, 3, p. 127-145 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.

    Minner, S., Rump, D., Tennstedt, P., Simon, R., Burandt, E. C., Terracciano, L., Moch, H., Wilczak, W., Bokemeyer, C., Fisch, M., Sauter, G. & Eichelberg, C., 2012, In: CANCER-AM CANCER SOC. 118, 5, p. 1268-1275 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

    Preukschas, M., Hagel, C., Schulte, A., Riecken, K., Lamszus, K., Sievert, H., Pällmann, N., Bokemeyer, C., Hauber, J., Balabanov, M. & Balabanov, S., 2012, In: PLOS ONE. 7, 8, p. 43468 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.

    Voigt, M., Braig, F., Goethel, M., Schulte, A., Lamszus, K., Bokemeyer, C. & Binder, M., 2012, In: NEOPLASIA. 14, 11, p. 1023-1031 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung.

    Grob, T., Kannengiesser, I., Tsourlakis, M. C., Atanackovic, D., König, A., Vashist, Y., Klose, H., Marx, A. H., Koops, S., Simon, R., Izbicki, J. R., Bokemeyer, C., Sauter, G. & Wilczak, W., 2012, In: MODERN PATHOL. 25, 12, p. 1566-1573 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Is advanced cancer associated with demoralization and lower global meaning? The role of tumor stage and physical problems in explaining existential distress in cancer patients.

    Vehling, S., Lehmann, C., Oechsle, K., Bokemeyer, C., Krüll, A., Koch-Gromus, U. & Mehnert, A., 2012, In: PSYCHO-ONCOLOGY. 21, 1, p. 54-63 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Kolorektale Tumoren: Individualisierte Therapiestrategien

    Stein, A. & Bokemeyer, C., 2012, In: Der Allgemeinarzt. 34, 20, p. 38-41 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.

    Kobold, S., Luetkens, T., Bartels, B. M., Cao, Y., Hildebrandt, Y., Sezer, O., Reinhard, H., Templin, J., Bartels, K., Lajmi, N., Haag, F., Bokemeyer, C., Kröger, N. & Atanackovic, D., 2012, In: Clin Dev Immunol. 2012, p. 134081

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.

    Ummanni, R., Barreto, F., Venz, S., Scharf, C., Barett, C., Mannsperger, H. A., Brase, J. C., Kuner, R., Schlomm, T., Sauter, G., Sültmann, H., Korf, U., Bokemeyer, C., Walther, R., Brümmendorf, T. & Balabanov, S., 2012, In: J PROTEOME RES. 11, 4, p. 2452-2466 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Protein-protein-interaction network organization of the hypusine modification system.

    Sievert, H., Venz, S., Platas-Barradas, O., Dhople, V. M., Schaletzky, M., Nagel, C-H., Balabanov, M., Preukschas, M., Pällmann, N., Bokemeyer, C., Brümmendorf, T., Pörtner, R., Walther, R., Duncan, K. E., Hauber, J. & Balabanov, S., 2012, In: MOL CELL PROTEOMICS. 11, 11, p. 1289-1305 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.

    Dyshlovoy, S. A., Naeth, I., Venz, S., Preukschas, M., Sievert, H., Jacobsen, C., Shubina, L. K., Manuela, G. S., Scharf, C., Walther, R., Krepstakies, M., Priyadarshini, P., Hauber, J., Fedorov, S. N., Bokemeyer, C., Stonik, V. A., Balabanov, S. & Honecker, F., 2012, In: J PROTEOME RES. 11, 4, p. 2316-2330 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. PTEN deletion is rare but often homogeneous in gastric cancer.

    Mina, S., Bohn, B., Simon, R., Krohn, A., Reeh, M., Arnold, D., Bokemeyer, C., Sauter, G., Izbicki, J. R., Marx, A. & Stahl, P., 2012, In: J CLIN PATHOL. 65, 8, p. 693-698 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Role of interleukin 16 in multiple myeloma.

    Atanackovic, D., Hildebrandt, Y., Templin, J., Cao, Y., Keller, C., Panse, J., Meyer, S., Reinhard, H., Bartels, K., Lajmi, N., Sezer, O., Zander, A. R., Marx, A., Uhlig, R., Zustin, J., Bokemeyer, C. & Kröger, N., 2012, In: JNCI-J NATL CANCER I. 104, 13, p. 1005-1020 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.

    Billecke, L., Murga-Penas, E-M., May, A. M., Engelhardt, M., Nagler, A., Leiba, M., Schiby, G., Kröger, N., Zustin, J., Marx, A., Matschke, J., Tiemann, M., Goekkurt, E., Bokemeyer, C. & Schilling, G., 2012, In: ANTICANCER RES. 32, 5, p. 2031-2034 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.

    Holstein, K., Marx, G., Lentz, B., Bokemeyer, C. & Langer, F., 2012, In: HAMOSTASEOLOGIE. 32 Suppl 1, p. 48-51

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.

    Spath, B., Hansen, A., Bokemeyer, C. & Langer, F., 2012, In: PLATELETS. 23, 1, p. 60-68 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature.

    Oliveira-Ferrer, L., Wellbrock, J., Balabanov, M., Klockow, M., Hauschild, J., Bokemeyer, C., Fiedler, W., Ergun, S. & Schuch, G., 2012, In: CANCER LETT. 326, 2, p. 161-167 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

    Canon, J-L., Vansteenkiste, J., Hedenus, M., Gascon, P., Bokemeyer, C., Ludwig, H., Vermorken, J., Legg, J., Pujol, B. & Bridges, K., 2012, In: MED ONCOL. 29, 3, p. 2291-2299 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2011

  22. Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis.

    Hennigs, J. K., Baumann, H. J., Schmiedel, S., Tennstedt, P., Sobottka, I., Bokemeyer, C., Kluge, S. & Klose, H., 01.12.2011, In: LUNG. 189, 6, p. 475-483 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

    Oechsle, K., Honecker, F., Cheng, T., Mayer, F., Czaykowski, P., Winquist, E., Wood, L., Fenner, M., Glaesener, S., Hartmann, J. T., Chi, K., Bokemeyer, C. & Kollmannsberger, C., 01.12.2011, In: ANN ONCOL. 22, 12, p. 2654-60 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. EAU guidelines on testicular cancer: 2011 update

    Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K., Horwich, A., Laguna, M. P. & European Association of Urology, 01.08.2011, In: EUR UROL. 60, 2, p. 304-319 16 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings.

    Beck, J., Procopio, G., Bajetta, E., Keilholz, U., Negrier, S., Szczylik, C., Bokemeyer, C., Bracarda, S., Richel, D. J., Staehler, M., Strauss, U. P., Mersmann, S., Burock, K. & Escudier, B., 01.08.2011, In: ANN ONCOL. 22, 8, p. 1812-1823 12 p., 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.

    Koychev, D., Oechsle, K., Bokemeyer, C. & Honecker, F., 01.08.2011, In: INT J ANDROL. 34, 4 Pt 2, p. 266-273 4 Pt 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score.

    Hessler, C., Vettorazzi, E., Madert, J., Bokemeyer, C. & Panse, J., 20.05.2011, In: SPINE. 36, 12, p. 983-989 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis

    Eichhorst, B. F., Fischer, K., Fink, A-M., Elter, T., Wendtner, C. M., Goede, V., Bergmann, M., Stilgenbauer, S., Hopfinger, G., Ritgen, M., Bahlo, J., Busch, R., Hallek, M., German CLL Study Group (GCLLSG) & Bokemeyer, C., 10.02.2011, In: BLOOD. 117, 6, p. 1817-21 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

    Otten, J., Schmitz, L., Vettorazzi, E., Schultze, A., Marx, A. H., Simon, R., Krauter, J., Loges, S., Sauter, G., Bokemeyer, C. & Fiedler, W., 01.02.2011, In: LEUKEMIA. 25, 2, p. 375-9 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.

    Laack, E., Simon, R., Regier, M., Andritzky, B., Tennstedt, P., Habermann, C., Verth, C. Z., Thoem, I., Grob, T., Sauter, G. & Bokemeyer, C., 01.01.2011, In: J THORAC ONCOL. 6, 1, p. 199-202 4 p., 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

    Balabanov, S., Gontarewicz, A., von Amsberg, G., Raddrizzani, L., Balabanov, M., Bosotti, R., Moll, J., Jost, E., Barett, C., Rohe, I., Bokemeyer, C., Holyoake, T. L. & Brümmendorf, T., 2011, In: PLOS ONE. 6, 4, p. 19164 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial.

    Schlemmer, M., Bauer, S., Schütte, R., Hartmann, J. T., Bokemeyer, C., Hosius, C. & Reichardt, P., 2011, In: EUR J MED RES. 16, 5, p. 206-212 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Akute Blutungen ohne Trauma - Gerinnung checken mit System

    Langer, F., Holstein, K. & Bokemeyer, C., 2011, In: Der Allgemeinarzt. 33, 15, p. 37-40 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).

    Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C. & Schmoll, H. J., 2011, In: ANN ONCOL. 22, p. 1054-1061

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.

    Atanackovic, D., Luetkens, T., Kloth, B., Fuchs, G., Cao, Y., Hildebrandt, Y., Meyer, S., Bartels, K., Reinhard, H., Lajmi, N., Hegewisch-Becker, S., Schilling, G., Platzbecker, U., Kobbe, G., Schroeder, T., Bokemeyer, C. & Kröger, N., 2011, In: AM J HEMATOL. 86, 11, p. 918-922 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Current standards and new trends in the primary treatment of colorectal cancer.

    Stein, A., Atanackovic, D. & Bokemeyer, C., 2011, In: EUR J CANCER. 47 Suppl 3, p. 312-314

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

    Bokemeyer, C., Bondarenko, I., Hartmann, J. T., de Braud, F., Schuch, G., Zubel, A., Celik, I., Schlichting, M. & Koralewski, P., 2011, In: ANN ONCOL. 22, 7, p. 1535-1546 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

    Minner, S. J. P., Enodien, M., Sirma, H., Lübke, A., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., Brase, J. C., Liu, A. Y., Schlüter, H., Pantel, K., Schumacher, U., Bokemeyer, C., Steuber, T., Graefen, M., Sauter, G. & Schlomm, T., 2011, In: CLIN CANCER RES. 17, 18, p. 5878-5888 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.

    Holweger, K., Lipp, H-P., Beijnen, J. H., Bokemeyer, C. & Hartmann, J. T., 2011, In: CANCER CHEMOTH PHARM. 68, 3, p. 693-701 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Global meaning and meaning-related life attitudes: exploring their role in predicting depression, anxiety, and demoralization in cancer patients.

    Vehling, S., Lehmann, C., Oechsle, K., Bokemeyer, C., Krüll, A., Koch-Gromus, U. & Mehnert, A., 2011, In: SUPPORT CARE CANCER. 19, 4, p. 513-520 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

    Minner, S. J. P., Wittmer, C., Graefen, M., Salomon, G., Steuber, T., Haese, A., Huland, H., Bokemeyer, C., Yekebas, E. F., Dierlamm, J., Balabanov, S., Kilic, E., Wilczak, W., Simon, R., Sauter, G. & Schlomm, T., 2011, In: PROSTATE. 71, 3, p. 281-288 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Histopathological and molecular features of late relapses in non-seminomas.

    Mayer, F., Wermann, H., Albers, P., Stoop, H., Gillis, A. J. M., Hartmann, J. T., Bokemeyer, C., Oosterhuis, J. W., Looijenga, L. H. J. & Honecker, F., 2011, In: BJU INT. 107, 6, p. 936-943 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Hodenkarzinom

    Winter, C., Rabenalt, R., Albers, P., Bokemeyer, C., Panse, J. & Schmidberger, H., 2011, Interdisziplinäre Entscheidungswege in der Onkologie: Diagnose- und Therapiealgorithmen mit Erläuterungen. Deutscher Ärzte-Verlag, p. 152-158 7 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  44. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

    Clauditz, T., Reiff, M., Gravert, L., Gnoss, A., Tsourlakis, M. C., Münscher, A., Sauter, G., Bokemeyer, C., Knecht, R. & Wilczak, W., 2011, In: PATHOLOGY. 43, 5, p. 459-464 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform.

    Ummanni, R., Mundt, F., Pospisil, H., Venz, S., Scharf, C., Barett, C., Fälth, M., Köllermann, J., Walther, R., Schlomm, T., Sauter, G., Bokemeyer, C., Sültmann, H., Schuppert, A., Brümmendorf, T. & Balabanov, S., 2011, In: PLOS ONE. 6, 2, p. 16833 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Kastrationsrefraktäres Prostatakarzinom - Second-line-Chemotherapie bietet Option auf Überlebensvorteil - Patientenselektion und Nebenwirkungsmanagement - Palliation tumorbedingter Beschwerden

    Bokemeyer, C., 2011, In: ONKOLOGE. 17, 7, p. 1-8 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.

    Oechsle, K., Kollmannsberger, C., Honecker, F., Mayer, F., Waller, C. F., Hartmann, J. T., Boehlke, I., Bokemeyer, C. & Group, G. T. C. S., 2011, In: EUR UROL. 60, 4, p. 850-855 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

    Minner, S. J. P., Kraetzig, F., Tachezy, M., Kilic, E., Graefen, M., Wilczak, W., Bokemeyer, C., Huland, H., Sauter, G. & Schlomm, T., 2011, In: HUM PATHOL. 42, 12, p. 1946-1952 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.

    Port, M., Gläsener, S., Ruf, C., Riecke, A., Bokemeyer, C., Meineke, V., Honecker, F. & Abend, M., 2011, In: MOL CANCER. 10, p. 52

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

    Hennigs, J. K., von Amsberg, G., Baumann, H. J., Honecker, F., Kluge, S., Bokemeyer, C., Brümmendorf, T. & Klose, H., 2011, In: BMC PULM MED. 11, p. 30

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.

    Kobold, S., Tams, S., Luetkens, T., Cao, Y., Sezer, O., Bartels, B. M., Reinhard, H., Templin, J., Bartels, K., Hildebrandt, Y., Lajmi, N., Marx, A., Haag, F., Bokemeyer, C., Kröger, N. & Atanackovic, D., 2011, In: Clin Dev Immunol. 2011, p. 302145

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Phase I trial of SU14813 in patients with advanced solid malignancies.

    Fiedler, W., Giaccone, G., Lasch, P., van der Horst, I., Brega, N., Courtney, R., Abbattista, A., Shalinsky, D. R., Bokemeyer, C. & Boven, E., 2011, In: ANN ONCOL. 22, 1, p. 195-201 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...8 9 10 11 12 13 14 15 16 Next